Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Madrigal Pharmaceuticals Inc (MDGL)

  • Event
  • Aug. 04, 2022, 00:00 UTC
  • 21
  • 1 comments

(47% Neutral) MADRIGAL PHARMACEUTICALS, INC. (MDGL) Reports 108% Loss Increase for 2022-06-30

Comment Full text

SpringWorks Therapeutics (SWTX)

  • Event
  • Aug. 04, 2022, 00:00 UTC
  • 21
  • 1 comments

(75% Positive) SPRINGWORKS THERAPEUTICS, INC. (SWTX) Reports 41% Loss Reduction for 2022-06-30

Comment Full text

Immunic Inc (IMUX)

  • Event
  • Aug. 04, 2022, 00:00 UTC
  • 25
  • 1 comments

(28% Negative) Immunic, Inc. (IMUX) Reports Net Loss for 2022-06-30

Comment Full text

COMPASS Pathways plc (CMPS)

  • Event
  • Aug. 04, 2022, 00:00 UTC
  • 19
  • 1 comments

(75% Positive) COMPASS Pathways plc (CMPS) Reports Net Loss for 2022-06-30

Comment Full text

Dyne Therapeutics Inc (DYN)

  • Event
  • Aug. 04, 2022, 00:00 UTC
  • 20
  • 1 comments

(61% Neutral) Dyne Therapeutics, Inc. (DYN) Reports Net Loss for 2022-06-30

Comment Full text

Provention Bio Inc (the company became a subdivision of the company Sanofi ADR (SNY)) (PRVB)

  • Event
  • Aug. 04, 2022, 00:00 UTC
  • 20
  • 1 comments

(38% Neutral) PROVENTION BIO, INC. (PRVB) Reports Net Loss for 2022-06-30

Comment Full text

Insmed Inc (INSM)

  • Event
  • Aug. 04, 2022, 00:00 UTC
  • 19
  • 1 comments

(51% Neutral) INSMED INC (INSM) Reports Net Loss for 2022-06-30

Comment Full text

Edgewise Therapeutics Inc (EWTX)

  • Event
  • Aug. 04, 2022, 00:00 UTC
  • 15
  • 1 comments

(76% Positive) Edgewise Therapeutics, Inc. (EWTX) Reports 44% Loss Reduction for 2022-06-30

Comment Full text

Magenta Therapeutics Inc (merged with Dianthus Therapeutics (DNTH)) (MGTA)

  • Event
  • Aug. 04, 2022, 00:00 UTC
  • 15
  • 1 comments

(47% Neutral) Magenta Therapeutics, Inc. (MGTA) Reports 77% Loss Increase for 2022-06-30

Comment Full text

Royalty Pharma (RPRX)

  • Event
  • Aug. 04, 2022, 00:00 UTC
  • 14
  • 1 comments

(70% Positive) Royalty Pharma plc (RPRX) Reports 43% Profit Growth for 2022-06-30

Comment Full text
  • Previous
  • 133
  • 134
  • 135
  • 136
  • 137
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189155)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124506)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin